LaVera Crawley

Administrative Appointments

• Advisory Board Member, Ethics Subcommittee, Center for Disease Control and Prevention, Office of the Director , (2009– 2013 )
• Board Member, Data Safety Monitoring Board, National Institute on Drug Abuse (NIDA) , (2007– present )

Honors and Awards

• Soros Faculty Scholar, Open Society Institute (1999-2001)
• Faculty Fellow, Stanford University School of Medicine (2007)

Professional Education

• MD, Meharry Medical College
• Residency, UC-San Francisco Family Medicine
• MPH, UC-Berkeley Interdisciplinary Public Health
• Fellow, Stanford School of Medicine Biomedical Ethics
• Fellow, Harvard Medical School Palliative Care Ed/Research

Research Interests

As an empirical bioethicist, my work focuses on social justice issues (broadly) and, more specifically, on health disparities and disease prevention among ethnic minority populations. Specific areas of my work have included: race-based disparities in palliative and end-of-life care; the impact of perceived medical discrimination on cancer screening behaviors among ethnic minority adults; disparities in patterns of direct-to-consumer advertising; and community-based participatory research projects targeting the elimination of health disparities related to cardio-metabolic risks among African American adults. I have an ongoing study on knowledge, attitudes, beliefs, and health and information-seeking behavior regarding the HPV vaccine among young adults and youth, employing an innovative strategy of social media research. I often use mixed-model and mixed-methods designs including: qualitative empirical methods (ethnography, grounded theory, narrative research); quantitative data collection and analysis; and innovative analytic techniques such as multiple correspondence analysis, text mining, and social network analysis.

Publications

• Direct-to-Consumer Advertising in Black and White: Racial Differences in Placement Patterns of Print Advertisements for Health Products and Messages. Crawley LM,  Hisaw L, Illes J.  Health Mark Q.  2009 Oct-Dec; 26 (4): 279-92
• Use of neurodevelopmental delay in pediatric solid organ transplant listing decisions: inconsistencies in standards across major pediatric transplant centers. Richards CT,  Crawley LM, Magnus D.  Pediatr Transplant.  2009; 13 (7): 843-50
• Research 2.0: Social Networking and DTC Genomics Lee, Sandra Soo-Jin,  Crawley, LaVera.  American Journal of Bioethics.  2009; 9 (6): 35-44
• Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Crawley LM,  Ahn DK, Winkleby MA.  Cancer Epidemiol Biomarkers Prev.  2008; 17 (8): 1937-44
• The Paradox of Race in the Bidil Debate Crawley, LM,  Journal of the National Medical Association.  2007; 99 (7): 821-2
• Racial, cultural, and ethnic factors influencing end-of-life care. Crawley LM,  J Palliat Med.  2005; 8 Suppl 1 S58-69
• Qualitative methods in end-of-life research: recommendations to enhance the protection of human subjects. Koenig BA,  Back AL, Crawley LM.  J Pain Symptom Manage.  2003; 25 (4): S43-52
• Miracles and medicine: helping families navigate the course. Crawley LM,  J Pain Symptom Manage.  2003; 25 (2): 192-4
• Strategies for culturally effective end-of-life care. Crawley LM,  Marshall PA, Lo B, Koenig BA.  Ann Intern Med.  2002; 136 (9): 673-9
• Palliative care in African American communities. Crawley LM,  J Palliat Med.  2002; 5 (5): 775-9
• African-American participation in clinical trials: situating trust and trustworthiness. Crawley LM,  J Natl Med Assoc.  2001; 93 (12 Suppl): 14S-17S
• Incorporating palliative care into primary care education. National Consensus Conference on Medical Education for Care Near the End of Life. Block SD,  Bernier GM, Crawley LM, Farber S, Kuhl D, Nelson W, O'Donnell J, Sandy L, Ury W.  J Gen Intern Med.  1998; 13 (11): 768-73
• Using resistant behaviors in the treatment of alcoholic patients. Crawley LM,  West J Med.  1987; 146 (4): 499-501